X0508 4/A 2025-11-25 2025-12-01 0001235912 CVRx, Inc. CVRX 0000200406 JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 false false true false 0000924020 Johnson & Johnson Innovation - JJDC, Inc. 410 GEORGE STREET NEW BRUNSWICK NJ 08901 false false true false false Common Stock 2025-11-25 4 S false 16000 10.03 D 4031198 I By Johnson & Johnson Innovation - JJDC, Inc. Common Stock 2025-11-26 4 S false 6337 10.03 D 4024861 I By Johnson & Johnson Innovation - JJDC, Inc. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.22. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"). JJDC is a wholly-owned subsidiary of Johnson & Johnson. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.23. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This Amendment to the Form 4 filed on 12/01/2025 is being filed to include the sale of shares on 11/25/2025, which was inadvertently omitted from the original filing due to an administrative oversight. Johnson & Johnson By /s/ Marc Larkins, Secretary 2026-01-08 Johnson & Johnson Innovation - JJDC, Inc. By: /s/ Jill McManus, Assistant Treasurer 2026-01-08